302 related articles for article (PubMed ID: 21785467)
1. MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.
Lakshmanan I; Ponnusamy MP; Das S; Chakraborty S; Haridas D; Mukhopadhyay P; Lele SM; Batra SK
Oncogene; 2012 Feb; 31(7):805-17. PubMed ID: 21785467
[TBL] [Abstract][Full Text] [Related]
2. MUC16 facilitates cervical cancer progression via JAK2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression.
Shen H; Guo M; Wang L; Cui X
Genes Genomics; 2020 Feb; 42(2):127-133. PubMed ID: 31736008
[TBL] [Abstract][Full Text] [Related]
3. MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression.
Matte I; Lane D; Boivin M; Rancourt C; Piché A
BMC Cancer; 2014 Apr; 14():234. PubMed ID: 24690311
[TBL] [Abstract][Full Text] [Related]
4. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.
Das S; Rachagani S; Torres-Gonzalez MP; Lakshmanan I; Majhi PD; Smith LM; Wagner KU; Batra SK
Oncotarget; 2015 Mar; 6(8):5772-87. PubMed ID: 25691062
[TBL] [Abstract][Full Text] [Related]
5. Mucin 16 Promotes Colorectal Cancer Development and Progression Through Activation of Janus Kinase 2.
Liu Z; Gu Y; Li X; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Xu T; Yang W; Huang Q
Dig Dis Sci; 2022 Jun; 67(6):2195-2208. PubMed ID: 33982216
[TBL] [Abstract][Full Text] [Related]
6. MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.
Lakshmanan I; Salfity S; Seshacharyulu P; Rachagani S; Thomas A; Das S; Majhi PD; Nimmakayala RK; Vengoji R; Lele SM; Ponnusamy MP; Batra SK; Ganti AK
Clin Cancer Res; 2017 Jul; 23(14):3906-3917. PubMed ID: 28196872
[No Abstract] [Full Text] [Related]
7. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract][Full Text] [Related]
9. Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.
Garg G; Gibbs J; Belt B; Powell MA; Mutch DG; Goedegebuure P; Collins L; Piwnica-Worms D; Hawkins WG; Spitzer D
BMC Cancer; 2014 Jan; 14():35. PubMed ID: 24447304
[TBL] [Abstract][Full Text] [Related]
10. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
11. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
[TBL] [Abstract][Full Text] [Related]
13. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
14. Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane.
Su Y; Tatzel K; Wang X; Belt B; Binder P; Kuroki L; Powell MA; Mutch DG; Hawkins WG; Spitzer D
Oncotarget; 2016 May; 7(21):31534-49. PubMed ID: 27120790
[TBL] [Abstract][Full Text] [Related]
15. Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231.
Choi YK; Seo HS; Choi HS; Choi HS; Kim SR; Shin YC; Ko SG
Mol Cell Biochem; 2012 Apr; 363(1-2):119-28. PubMed ID: 22147197
[TBL] [Abstract][Full Text] [Related]
16. CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells.
Reinartz S; Failer S; Schuell T; Wagner U
Eur J Cancer; 2012 Jul; 48(10):1558-69. PubMed ID: 21852110
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
18. Furano-1,2-naphthoquinone inhibits EGFR signaling associated with G2/M cell cycle arrest and apoptosis in A549 cells.
Su JC; Lin KL; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
Cell Biochem Funct; 2010 Dec; 28(8):695-705. PubMed ID: 21104938
[TBL] [Abstract][Full Text] [Related]
19. Momordica cochinchinensis Spreng. seed extract suppresses breast cancer growth by inducing cell cycle arrest and apoptosis.
Zheng L; Zhang Y; Liu Y; Yang XO; Zhan Y
Mol Med Rep; 2015 Oct; 12(4):6300-10. PubMed ID: 26252798
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
Comamala M; Pinard M; Thériault C; Matte I; Albert A; Boivin M; Beaudin J; Piché A; Rancourt C
Br J Cancer; 2011 Mar; 104(6):989-99. PubMed ID: 21326240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]